Archive for the ‘pharmaceutical class action’ Category
Pfizer class action filed over Neurontin
The world’s largest pharmaceutical company, Pfizer Inc. (NYSE:PFE), now faces a Canadian class action alleging that it failed to warn consumers about the risks of its epilepsy drug Neurontin. In Toronto, Justice Paul Perell of Ontario Superior Court in Toronto certified the class action to cover consumers in every province except Quebec, according to court [...]